Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap-IPV Booster Immune Response in Children with Different Priming Histories
NCT04300192Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Quadracel in pertussis, diphtheria, Tetanus, poliomyelitis, sponsored by Sanofi. Started Jan 2021; status: completed.
02
Drugs
Quadracel
03
Conditions
pertussisdiphtheriaTetanuspoliomyelitis
Beyond the preview
Go deeper on NCT04300192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04300192.